StemCells, Inc. (NASDAQ:STEM)
A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
pchop123
(70.23)
Submitted: 2/3/2012 12:27:08 PM :
Start Price:
$1.08
STEM Score:
-7.38
stem cells may be gaining momentum again
Recs
usubanas
(99.75)
Submitted: 2/3/2012 11:57:06 AM :
Start Price:
$1.09
STEM Score:
-8.18
market cap: 15 million
starting phase 1/2 trial in dry AMD
no available therapies for dry AMD
dry AMD is 90% of AMD, wet AMD is 10%
wet AMD Lucentis sales: 1.6 billion
connect the dots...
Recs
Recs
jimscottage11
(< 20)
Submitted: 12/19/2011 6:45:19 AM :
Start Price:
$0.83
STEM Score:
+10.40
Hit new 52 week low of .82 on Friday 16th 2011. Dropped 40% on friday. Should bounce back
Recs
Haugurafpeningum
(98.39)
Submitted: 11/8/2011 2:33:29 AM :
Start Price:
$1.97
STEM Score:
-55.10
Technical Monthly
Recs
Gerf1
(32.83)
Submitted: 9/20/2011 10:07:57 AM :
Start Price:
$2.38
STEM Score:
-69.49
this research will be very beneficial to help humans in so many ways, should also make $$$ if succesufull and managed correctly, and used for good not bad.
Recs
Recs
Recs
stemcells2011
(< 20)
Submitted: 4/13/2011 11:52:09 AM :
Start Price:
$7.85
STEM Score:
-89.62
Stem cells
Recs
bshope
(< 20)
Submitted: 3/28/2011 3:39:06 PM :
Start Price:
$8.60
STEM Score:
-90.85
Their upcoming clinical trials will be a big news story.
Recs
Covestor
(< 20)
Submitted: 3/14/2011 3:06:38 PM :
Start Price:
$8.44
STEM Score:
-91.63
Covestor Model Manager Joe Agresti bought STEM in his China & India Covestor Model ( http://covestor.com/Joe-Agresti )
Recs
chilloutsessions
(65.72)
Submitted: 3/14/2011 10:04:35 AM :
Start Price:
$8.49
STEM Score:
-91.37
Long term buy.
Recs
HollowMountain
(< 20)
Submitted: 2/18/2011 4:33:19 AM :
Start Price:
$9.65
STEM Score:
-89.63
I keep doing screens to find new ideas, and I always run into this one, I like the sector and the fundamentals aren't TOO bad. Plus with a possible first mover in a hyped sector, this could pop on speculation alone.
Recs
samdeva
(83.04)
Submitted: 1/21/2011 3:18:41 PM :
Start Price:
$9.80
STEM Score:
-94.31
Mostly intuition (sorry, could have better explanation). I picked AMRN in 2008 from my intuition, which gave me 300% return in 2 years. So, trusting my intuition again.
Recs
tltheleno
(< 20)
Submitted: 1/12/2011 1:42:53 PM :
Start Price:
$9.97
STEM Score:
-94.49
Stem cell is going to major. Needs more time.
Recs
Recs
whomonkyoulus
(28.09)
Submitted: 8/19/2010 4:35:32 AM :
Start Price:
$11.40
STEM Score:
-114.25
I am not going to try to time this one. I think that this will be worth a billion USD in 5 more years.
Recs
jkleiman
(55.40)
Submitted: 10/5/2009 3:36:52 PM :
Start Price:
$15.30
STEM Score:
-122.75
Hard to value a stock like this. It's a long-term buy. Eventually stem cells will play a huge rule in modern medicine. When is only a matter of time, and Bush or Jesus or any of their pals can always set science back
Recs
englandstumpy
(20.78)
Submitted: 8/5/2009 1:54:11 PM :
Start Price:
$16.90
STEM Score:
-128.23
Obama is infavor of this research and will remove restrictions and possibly add funding.
Recs
Wiseinvest70
(52.85)
Submitted: 7/27/2009 2:46:29 PM :
Start Price:
$18.00
STEM Score:
-132.02
Stem cell research will be one of the major technologies in the years to come, at this moment is like buying the coke recipe for a peanuts, in my time frame I'm suggesting a 2 to 4 year period, but this baby is a one to keep for at least 10 years where we will see a major change in the way we know health industry.
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 91 : 1 2 3 4 5 Next »